Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB7 | Q14451 | 1/20 | 0.54 |
| ▸ | ROR1 | Q01973 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21664063 | 0.90 | GRB7 (0.54) | GRB7ROR1OPRM1OPRD1OPRK1 | |
| SCHEMBL21664109 | 0.79 | OPRM1 (0.49) | OPRM1OPRD1OPRK1 | |
| SCHEMBL15748376 | 0.72 | GRB7 (0.72) | GRB7ROR1 | |
| SCHEMBL21664113 | 0.72 | GRB7 (0.49) | GRB7 | |
| SCHEMBL21664111 | 0.71 | FLT1 (0.48) | GRB7 | |
| SCHEMBL30389411 | 0.71 | FLT1 (0.49) | GRB7ROR1OPRM1OPRD1OPRK1 | |
| SCHEMBL30637590 | 0.69 | OPRM1 (0.55) | OPRM1OPRD1OPRK1 | |
| SCHEMBL30637487 | 0.69 | OPRM1 (0.55) | OPRM1OPRD1OPRK1 | |
| SCHEMBL30637599 | 0.69 | OPRM1 (0.55) | OPRM1OPRD1OPRK1 | |
| SCHEMBL30637559 | 0.69 | OPRM1 (0.55) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | FUJIFILM CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | VIP, NPPA, NGLY1 | GRB7 1028/4885ROR1 2553/4885OPRM1 3711/4885 |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | VIP, NPPA, NGLY1 | GRB7 1028/4885ROR1 2553/4885OPRM1 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.